Diyne polycyclotrimerizations initiated by transition-metal catalysts afforded hyperbranched polyphenylenes, which exhibited low viscosity, outstanding thermal stability, and small optical dispersion. Under optimized reaction conditions, polycyclotrimerizations of 1,8-nonadiyne (1) and 1,9-decadiyne (2) catalyzed by TaCl 5-Ph4Sn produced hyperbranched poly(1,2,4-benzenetriyl-1,5-pentanediyl) (3) and poly-(1,2,4-benzenetriyl-1,6-hexanediyl) (4), 1-5 respectively, in high yields (up to 93%). The polymers were completely soluble and film-forming, and possessed high molecular weights (Mw up to ∼1.4 × 10 6 ) but low intrinsic viscosities ([η] down to 0.13 dL/g). Their structures and properties were analyzed and evaluated by IR, UV, NMR, SEC, TGA, DSC, spectrofluorometry, light scattering, and spectroellipsometry. The structural characterizations confirmed the expected hyperbranched molecular architectures of 3 and 4 (comprising of 1,2,4-benzene rings and R,ω-alkyl spacers) and revealed the regioselective feature of the diyne polycyclotrimerizations. Polymers 3 and 4 underwent glass transitions at 43 and 23 °C, respectively, and lost almost no weights when heated to ∼500 °C. Polymer 3 emitted UV light upon excitation, whereas 4 was practically nonluminescent. The thin films of 3 were highly transparent (g99.5% transmittance) and displayed an optical dispersion as low as 0.009 in the visible spectral region, much superior to those of the commercially important "organic glasses" such as poly(methyl methacrylate) and polycarbonates.

No abstract

We have developed an immunotherapeutic approach with potential application in the treatment of viral and malignant disease. We show that primary CD8+ T cells isolated from peripheral blood can be genetically modified by retroviral transduction to express high levels of universal (major histocompatibility complex-unrestricted) chimeric T- cell receptors specific for human immunodeficiency virus (HIV) antigens. Two classes of HIV-specific URs in which the antigen-binding domain is comprised of either CD4 or a single-chain antibody are capable of activating a number of T-cell effector functions in response to target cells, including cytolysis, in a highly sensitive and specific manner. Importantly, we have addressed a number of issues which, although particularly relevant to the clinical application of this approach in the treatment of HIV infection, may also impact on the potential of UR immunotherapy for other disease targets. The UR immunotherapeutic system is particularly suited for evaluation in the clinical setting.

GEM 91 (gene expression modulator) is a 25-mer oligonucleotide phosphorothioate complementary to the gag initiation site of HIV-1. GEM 91 has been studied in various in vitro cell culture models to examine inhibitory effects on different stages of HIV-1 replication. Experiments were focused on the binding of virions to the cell surface, inhibition of virus entry, reverse transcription (HIV DNA production), inhibition of steady state viral mRNA levels, inhibition of virus production from chronically infected cells, and inhibition of HIV genome packaging within virions. Experiments were also performed in vitro in an attempt to generate strains of HIV with reduced sensitivity to GEM 91. We observed sequence-dependent inhibition of virus entry/reverse transcription and a reduction in steady state viral RNA levels. We also observed sequence-independent inhibition of virion binding to cells and inhibition of virus production by chronically infected cells. Using in vitro methods that were successful in generating HIV strains with reduced sensitivity to AZT, we were unable to generate strains with reduced sensitivity to GEM 91.

The hyperbranched copolymers were obtained by the atom transfer radical copolymerization of p‐(chloromethyl)styrene (CMS) with N‐cyclohexylmaleimide (NCMI) catalyzed by CuCl/2,2′‐bipyridine (bpy) in cyclohexanone (C6H10O) or anisole (PhOCH3) with CMS as the inimer. The influences of several factors, such as temperature, solvent, the concentration of CuCl and bpy, and monomer ratio, on the copolymerization were subsequently investigated. The apparent enthalpy of activation for the overall copolymerization was measured to be 37.2 kJ/mol. The fractional orders obtained in the copolymerization were approximately 0.843 and 0.447 for [CuCl]0 and [bpy]0, respectively. The monomer reactivity ratios were evaluated to be rNCMI = 0.107 and rCMS = 0.136. The glass transition temperature of the resultant hyperbranched copolymer increases with increasing fNCMI, which indicates that the heat resistance of the copolymer has been improved by increasing NCMI. The prepared hyperbranched CMS/NCMI copolymers were used as macroinitiators for the solution polymerization of styrene to yield star‐shaped poly(CMS‐co‐NCMI)/polystyrene block copolymers by atom transfer radical polymerization. © 2000 John Wiley & Sons, Inc. J Appl Polym Sci 78: 1992–1997, 2000

We have developed a humanized, bispecific immunoadhesin-antibody (BsIAb) that targets and kills HIV-infected cells. Comprised of CD4-IgG and humanized anti-CD3-IgG, this BsIAb is bifunctional. First, in targeting, it exploits the natural affinity of CD4 for gp120 to target the BsIAb to HIV-infected cells, and second, it recruits and activates, through its anti-CD3 moiety, cytotoxic T lymphocytes (CTL) to lyse target cells in a non-MHC restricted manner. To produce purified BsIAb from supernantants of transfected mammalian cells, we designed a three-step recovery scheme based on the structural elements of this heterotrimeric protein. The ability of purified BsIAb to specifically lyse HIV-infected target cells was demonstrated using CTL from two different sources: whole peripheral blood lymphocyte (PBL) fractions and pure CTL preparations. In contrast, a human anti-gp120 antibody mediated lysis of HIV-infected target cells only with PBL fractions and not with purified CTL. Moreover, lysis observed in the presence of the human anti-gp120 antibody was completely blocked in the presence of human serum (which competes for Fc gamma receptor binding), whereas BsIAb-mediated lysis of target cells was not affected. We measured the monovalent affinities of BsIAb for HIV-gp120 on infected cells and for CD3 epsilon on CTL. Relative to the bivalent parent molecules, CD4/gp120 affinity in the BsIAb is unchanged, whereas anti-CD3/CD3 is substantially decreased. We further demonstrated by fluorescence microscopy that physical association of CD3+ cells with gp120-expressing cells occurs only in the presence of BsIAb. Thus, the cytocidal activity of BsIAb in the presence of serum reflects its unique ability to recruit CTL as effector cells and highlights a potentially important advantage of this type of construct over antibodies for HIV-directed therapy.

No abstract

No abstract